Corcept Therapeutics Stock Target Price and Analyst Consensus
| CORT Stock | USD 50.86 0.89 1.78% |
The current analyst and expert consensus on Corcept Therapeutics is Strong Buy, with 3 strong buy opinions. The current projected Corcept Therapeutics target price consensus is 74.90 with 5 analyst opinions. Check out Macroaxis Advice on Corcept Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Corcept Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Corcept Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Corcept Therapeutics. We strongly encourage you to use your own analysis of Corcept Therapeutics to validate this buy or sell advice. Corcept Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Corcept Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 2.8063.
Lowest Forecast 68.16 | Highest Forecast 83.14 | Target Price 74.9 |
Corcept |
It's important to approach Corcept Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Corcept Therapeutics Target Price Consensus
Corcept target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Corcept Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Corcept analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Corcept stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Corcept Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCorcept Therapeutics Target Price Projection
Corcept Therapeutics' current and average target prices are 50.86 and 74.90, respectively. The current price of Corcept Therapeutics is the price at which Corcept Therapeutics Incorporated is currently trading. On the other hand, Corcept Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Corcept Therapeutics Market Quote on 4th of January 2025
Target Price
Analyst Consensus On Corcept Therapeutics Target Price
Corcept Therapeutics Analyst Ratings
Corcept Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Corcept Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Corcept Therapeutics' financials, market performance, and future outlook by experienced professionals. Corcept Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Corcept Therapeutics price targets
Corcept Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Corcept Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Corcept Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Corcept Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Corcept Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Corcept Therapeutics is a key component of Corcept Therapeutics valuation and have some predictive power on the future returns of a Corcept Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Impulse Invested over 100 shares | |
 | Momentum Invested few shares | |
 | Blockchain Invested few shares | |
 | Social Domain Invested few shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Investor Favorites Invested over 300 shares | |
 | Business Services Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Manufacturing Invested over 40 shares | |
 | Banking Invested over 30 shares | |
 | Hedge Favorites Invested over 40 shares |
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.